AIP Insider Sells 30,538 Shares; 6,421 RSUs to Trade on 10/07/2025
Rhea-AI Filing Summary
Arteris, Inc. filing a Form 144 notifies a proposed sale of 6,421 common shares (acquired as restricted stock units) with an aggregate market value of $87,197.18, through Morgan Stanley Smith Barney LLC on or about 10/07/2025. The RSUs were recorded as acquired on 10/01/2025 and the filing lists previous sales by the same person totaling 30,538 shares during the prior three months, generating gross proceeds of $336,546.61. The filer affirms no undisclosed material adverse information and references Rule 10b5-1 sales plans used for several prior transactions.
Positive
- Transaction transparency: Filing discloses the proposed sale amount and broker (Morgan Stanley Smith Barney LLC)
- Source of shares clear: Shares to be sold were acquired as Restricted Stock Units on 10/01/2025
Negative
- Significant insider selling: 30,538 shares sold in prior three months for gross proceeds of $336,546.61
- Additional near-term sale: Proposed sale of 6,421 shares on or about 10/07/2025, increasing insider supply
Insights
TL;DR: Insider proposes sale of RSUs and has executed material sales recently.
The filing shows a proposed sale of 6,421 shares acquired as restricted stock units on 10/01/2025
Prior sales by the same person total 30,538 shares for gross proceeds of $336,546.61 over the past three months, with multiple trades executed under 10b5-1 plans. The immediate dependency is the timing noted as "approximate date of sale" 10/07/2025, and execution will occur via Morgan Stanley Smith Barney LLC.
Watch for the actual execution on 10/07/2025 and any subsequent amendment disclosing a different sale amount or cancellation; continued selling at this scale relative to outstanding shares could be meaningful to supply, though no financial performance metrics are provided here.